VRTX
VERTEX PHARMACEUTICALS INC / MA
NASDAQ · Healthcare · Biotechnology · US
$549.04
+3.44%Margins
Gross margin
85.6%
EBITDA margin
38.2%
EBIT margin
33.9%
Net margin
30.6%
FCF margin
24.7%
19.0%
Return on equity
12.1%
Return on assets
16.1%
Return on invested capital
0.43x
Asset turnover
$3.7B
Cash from operations
$25
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Sep 1, 2026